137 related articles for article (PubMed ID: 10449972)
1. Molecular aspects of pancreatic cancer and future perspectives.
Friess H; Kleeff J; Korc M; Büchler MW
Dig Surg; 1999; 16(4):281-90. PubMed ID: 10449972
[TBL] [Abstract][Full Text] [Related]
2. Growth factors and their receptors in pancreatic cancer.
Ozawa F; Friess H; Tempia-Caliera A; Kleeff J; Büchler MW
Teratog Carcinog Mutagen; 2001; 21(1):27-44. PubMed ID: 11135319
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic cancer--new aspects of molecular biology research.
Kleeff J; Friess H; Berberat PO; Martignoni ME; Z'graggen K; Büchler MW
Swiss Surg; 2000; 6(5):231-4. PubMed ID: 11077487
[TBL] [Abstract][Full Text] [Related]
4. Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model.
Gore J; Imasuen-Williams IE; Conteh AM; Craven KE; Cheng M; Korc M
Cancer Lett; 2016 Aug; 379(1):143-53. PubMed ID: 27267807
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.
Goggins M; Shekher M; Turnacioglu K; Yeo CJ; Hruban RH; Kern SE
Cancer Res; 1998 Dec; 58(23):5329-32. PubMed ID: 9850059
[TBL] [Abstract][Full Text] [Related]
6. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival.
Shin SH; Kim SC; Hong SM; Kim YH; Song KB; Park KM; Lee YJ
Pancreas; 2013 Mar; 42(2):216-22. PubMed ID: 23344532
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer: factors regulating tumor development, maintenance and metastasis.
Shi X; Friess H; Kleeff J; Ozawa F; Büchler MW
Pancreatology; 2001; 1(5):517-24. PubMed ID: 12120231
[TBL] [Abstract][Full Text] [Related]
9. Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells.
Villanueva A; García C; Paules AB; Vicente M; Megías M; Reyes G; de Villalonga P; Agell N; Lluís F; Bachs O; Capellá G
Oncogene; 1998 Oct; 17(15):1969-78. PubMed ID: 9788440
[TBL] [Abstract][Full Text] [Related]
10. Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cancer.
Zhong Y; Macgregor-Das A; Saunders T; Whittle MC; Makohon-Moore A; Kohutek ZA; Poling J; Herbst BT; Javier BM; Cope L; Leach SD; Hingorani SR; Iacobuzio-Donahue CA
Clin Cancer Res; 2017 Mar; 23(6):1607-1620. PubMed ID: 27637888
[No Abstract] [Full Text] [Related]
11. Altered expression of TGFB receptors and mitogenic effects of TGFB in pancreatic carcinomas.
Jonson T; Albrechtsson E; Axelson J; Heidenblad M; Gorunova L; Johansson B; Höglund M
Int J Oncol; 2001 Jul; 19(1):71-81. PubMed ID: 11408925
[TBL] [Abstract][Full Text] [Related]
12. [Pancreatic carcinogenesis. Clinical implications].
Schneider G; Lersch C; Schmid RM
Chirurg; 2003 Mar; 74(3):165-70. PubMed ID: 12647072
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors.
Friess H; Berberat P; Schilling M; Kunz J; Korc M; Büchler MW
J Mol Med (Berl); 1996 Jan; 74(1):35-42. PubMed ID: 8834768
[TBL] [Abstract][Full Text] [Related]
14. Angiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomes.
Craven KE; Gore J; Wilson JL; Korc M
Oncotarget; 2016 Jan; 7(1):323-41. PubMed ID: 26586478
[TBL] [Abstract][Full Text] [Related]
15. Emodin inhibits angiogenesis in pancreatic cancer by regulating the transforming growth factor-β/drosophila mothers against decapentaplegic pathway and angiogenesis-associated microRNAs.
Lin SZ; Xu JB; Ji X; Chen H; Xu HT; Hu P; Chen L; Guo JQ; Chen MY; Lu D; Wang ZH; Tong HF
Mol Med Rep; 2015 Oct; 12(4):5865-71. PubMed ID: 26238071
[TBL] [Abstract][Full Text] [Related]
16. Molecular pattern of ductal pancreatic cancer.
Sirivatanauksorn V; Sirivatanauksorn Y; Lemoine NR
Langenbecks Arch Surg; 1998 Apr; 383(2):105-15. PubMed ID: 9641882
[TBL] [Abstract][Full Text] [Related]
17. Growth factors and cytokines in pancreatic carcinogenesis.
Friess H; Guo XZ; Nan BC; Kleeff J; Büchler MW
Ann N Y Acad Sci; 1999 Jun; 880():110-21. PubMed ID: 10415856
[TBL] [Abstract][Full Text] [Related]
18. Transfection of the type I TGF-beta receptor restores TGF-beta responsiveness in pancreatic cancer.
Wagner M; Kleeff J; Lopez ME; Bockman I; Massaqué J; Korc M
Int J Cancer; 1998 Oct; 78(2):255-60. PubMed ID: 9754660
[TBL] [Abstract][Full Text] [Related]
19. Serine/threonine kinase receptors.
ten Dijke P; Franzén P; Yamashita H; Ichijo H; Heldin CH; Miyazono K
Prog Growth Factor Res; 1994; 5(1):55-72. PubMed ID: 8199354
[TBL] [Abstract][Full Text] [Related]
20. Frequent expression of genes for receptor tyrosine kinases and their ligands in human pancreatic cancer cells.
Oikawa T; Hitomi J; Kono A; Kaneko E; Yamaguchi K
Int J Pancreatol; 1995 Aug; 18(1):15-23. PubMed ID: 7594766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]